Lee Su-Leng Tan
Chief Executive Officer, Director, 10% Owner · BioNexus Gene Lab Corp
Individual
- 2026
- Aug 14, 2026
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Lee Su-Leng Tan's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Mark A. Goldsmith - $56.99M in RVMD purchases and sales in the last 12 months
- Peter A. Thompson - $55.67M in SION purchases and sales in the last 12 months
- ORBIMED ADVISORS LLC - $55.67M in SION purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $55.46M in COAG purchases and sales in the last 12 months
- John E. Kao - $54.16M in ALHC purchases and sales in the last 12 months
- Mahkam Zanganeh - $51.95M in SMMT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Lee Su-Leng Tan?
Lee Su-Leng Tan is a corporate insider, tracked as Chief Executive Officer, Director, 10% Owner of BioNexus Gene Lab Corp (BGLC). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Lee Su-Leng Tan submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
